Yanqun Shu

Yanqun Shu is a molecular and cell biologist with over 15 years of experience in research and discovery.1 They currently hold the position of Platform and In Vitro Biology Lead at Skyline Therapeutics, based in Cambridge.1

While specific details about Yanqun Shu's career progression are limited in the provided search results, we can infer that they have significant expertise in molecular and cellular biology, which is likely crucial for their role in platform development and in vitro biology at Skyline Therapeutics.

Skyline Therapeutics appears to be a biotechnology company, and Yanqun Shu's role as a lead in platform and in vitro biology suggests they are involved in developing and optimizing biological systems and techniques for the company's therapeutic research and development efforts.

Given their extensive experience in the field, it's likely that Yanqun Shu plays a key role in advancing Skyline Therapeutics' research initiatives and contributing to the company's scientific strategy.